Filana Therapeutics (SAVA) Q3 2024 Earnings

8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.77
-0.47
-0.17
0.13

Details

Expected EPS
-0.406667
Actual EPS
0.13
Surprise EPS
0.54
Surprise Percent
+131.97%

Description

Filana Therapeutics (SAVA) has reported earnings of 0.13 per share for Q3 2024.

0 Comments

Share your thoughts